AU679723B2 - Diarylalkyl piperidines useful as multi-drug resistant tumoragents - Google Patents

Diarylalkyl piperidines useful as multi-drug resistant tumoragents Download PDF

Info

Publication number
AU679723B2
AU679723B2 AU60148/94A AU6014894A AU679723B2 AU 679723 B2 AU679723 B2 AU 679723B2 AU 60148/94 A AU60148/94 A AU 60148/94A AU 6014894 A AU6014894 A AU 6014894A AU 679723 B2 AU679723 B2 AU 679723B2
Authority
AU
Australia
Prior art keywords
international
document
hydrogen
date
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU60148/94A
Other languages
English (en)
Other versions
AU6014894A (en
Inventor
Jules Freedman
Sai P. Sunkara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of AU6014894A publication Critical patent/AU6014894A/en
Application granted granted Critical
Publication of AU679723B2 publication Critical patent/AU679723B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU60148/94A 1993-01-21 1993-12-17 Diarylalkyl piperidines useful as multi-drug resistant tumoragents Ceased AU679723B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US656993A 1993-01-21 1993-01-21
US006569 1993-01-21
PCT/US1993/012300 WO1994017040A1 (en) 1993-01-21 1993-12-17 Diarylalkyl piperidines useful as multi-drug resistant tumor agents

Publications (2)

Publication Number Publication Date
AU6014894A AU6014894A (en) 1994-08-15
AU679723B2 true AU679723B2 (en) 1997-07-10

Family

ID=21721516

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60148/94A Ceased AU679723B2 (en) 1993-01-21 1993-12-17 Diarylalkyl piperidines useful as multi-drug resistant tumoragents

Country Status (20)

Country Link
US (1) US5648365A (online.php)
EP (1) EP0680470B1 (online.php)
JP (1) JP3398748B2 (online.php)
KR (1) KR100377280B1 (online.php)
AT (1) ATE150748T1 (online.php)
AU (1) AU679723B2 (online.php)
CA (1) CA2152794C (online.php)
DE (1) DE69309310T2 (online.php)
DK (1) DK0680470T3 (online.php)
ES (1) ES2102830T3 (online.php)
FI (1) FI112474B (online.php)
GR (1) GR3023188T3 (online.php)
HU (1) HUT72078A (online.php)
IL (1) IL108369A (online.php)
MX (1) MX9400563A (online.php)
NO (1) NO305166B1 (online.php)
NZ (1) NZ261414A (online.php)
TW (1) TW243445B (online.php)
WO (1) WO1994017040A1 (online.php)
ZA (1) ZA94317B (online.php)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT70564A (en) * 1992-02-06 1995-10-30 Merrell Dow Pharma Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives
WO2001007034A1 (en) * 1999-07-23 2001-02-01 Colorado State University Research Foundation Multidrug resistance pump inhibitors and uses thereof
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
WO2003041128A2 (en) * 2001-11-07 2003-05-15 Pharmacia Corporation Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
US8153184B2 (en) * 2001-11-26 2012-04-10 Samsung Mobile Display Co., Ltd. Organic EL display device and method of manufacturing the same
KR100656490B1 (ko) * 2001-11-26 2006-12-12 삼성에스디아이 주식회사 풀칼라 유기전계 발광표시소자 및 그의 제조방법
ES2675215T3 (es) 2013-02-08 2018-07-09 General Mills, Inc. Productos alimentarios reducidos en sodio
CN110372571B (zh) * 2018-04-12 2022-11-15 中国科学院大连化学物理研究所 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016044A1 (en) * 1992-02-06 1993-08-19 Merrell Dow Pharmaceuticals Inc. Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1049377B (de) * 1952-04-03 1959-01-29 Abbott Laboratories, North Chicago, 111. (V. St. A.) Verfahren zur Herstellung von substituierten Vinylpiperidinen
US2898339A (en) * 1957-07-29 1959-08-04 Wm S Merrell Co N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US4035372A (en) * 1976-08-13 1977-07-12 G. D. Searle & Co. 4-{[4-(Diphenylmethyl)-1-piperidinyl]methyl}benzenamines
EP0235463A3 (en) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
US4990511A (en) * 1988-08-03 1991-02-05 Takeda Chemical Industries, Ltd. Amide compounds, their production and use
HUT59377A (en) * 1989-06-19 1992-05-28 Wellcome Found Process for producing drugs containing new aromatic rings
GB9000305D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Anticholinergic agents
EP0467435A3 (en) * 1990-07-19 1992-04-01 Akzo N.V. Benzhydryl derivatives having calmodulin inhibitor properties
EP0471612B1 (fr) * 1990-08-14 1998-01-28 Roussel Uclaf Nouveaux 19-Nor stéroides ayant en position 11béta une chaíne carbonée comportant une fonction amide, leur préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016044A1 (en) * 1992-02-06 1993-08-19 Merrell Dow Pharmaceuticals Inc. Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives

Also Published As

Publication number Publication date
FI953506L (fi) 1995-07-20
NO952885L (no) 1995-09-20
NZ261414A (en) 1997-06-24
DE69309310T2 (de) 1997-11-06
WO1994017040A1 (en) 1994-08-04
KR960700230A (ko) 1996-01-19
DK0680470T3 (online.php) 1997-04-28
EP0680470B1 (en) 1997-03-26
US5648365A (en) 1997-07-15
JP3398748B2 (ja) 2003-04-21
TW243445B (online.php) 1995-03-21
ZA94317B (en) 1994-08-18
AU6014894A (en) 1994-08-15
KR100377280B1 (ko) 2003-07-18
DE69309310D1 (de) 1997-04-30
ATE150748T1 (de) 1997-04-15
FI112474B (fi) 2003-12-15
CA2152794C (en) 1999-04-06
FI953506A0 (fi) 1995-07-20
EP0680470A1 (en) 1995-11-08
IL108369A (en) 1999-08-17
IL108369A0 (en) 1994-04-12
JPH08505870A (ja) 1996-06-25
NO305166B1 (no) 1999-04-12
ES2102830T3 (es) 1997-08-01
NO952885D0 (no) 1995-07-20
CA2152794A1 (en) 1994-08-04
GR3023188T3 (en) 1997-07-30
HU9502195D0 (en) 1995-09-28
HUT72078A (en) 1996-03-28
MX9400563A (es) 1994-07-29

Similar Documents

Publication Publication Date Title
Alwan et al. Novel imidazo [2, 1-b]-1, 3, 4-thiadiazoles as promising antifungal agents against clinical isolate of Cryptococcus neoformans
ES2906785T3 (es) Pirazoles 3,5-disustituidos útiles como inhibidores de la quinasa de punto de control 1 (CHK1), y sus preparaciones y aplicaciones
EP0680470B1 (en) Diarylalkyl piperidines useful as multi-drug resistant tumor agents
US10087149B2 (en) Selective histone deacetylase 8 inhibitors
AU2005266493B2 (en) Inhibitors of Hsp90
AU698673B2 (en) Heterocyclic chemistry
AU662602B2 (en) Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives
CA2176016A1 (en) Antiarrhythmic benzodiazepines
US5190957A (en) Treatment of multi-drug resistant tumors with quinolyl-and isoquinolyloxazole-2-ones
EP0428107B1 (en) Use of quinolyl-and isoquinolyloxanole-2-ones for the production of a medicament for the treatment of multi-drug resistant tumors
HU201082B (en) Enolethers of 6-chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carboxylic acid amide-1,1-dioxide, a process for their preparation and their use.
US5670521A (en) Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives
US6589975B2 (en) Synthetic compounds for treatment of inflammation
AR013222A1 (es) Derivados de 3-oxadiazolil-1,6-naftiridin-2(1h)-ona-5-sustituidos; compuestos intermedios utiles en la preparacion de dichos derivados; composiciones farmaceuticas que comprenden dichos derivados y medicamentos capaces de actuar sobre receptores de benzodiacepinas que incluyen dichos derivados.
US4131683A (en) ω-(1,3-Dithiolan-2-imino) substituted acetic acids
US3344186A (en) 2-guanidino-1, 2, 3, 4-tetrahydronaphthalene and salts thereof
US6346620B1 (en) Methods for preparation of 2-(4-(4-(4,5-dichloro-2-methylimidazol-1-yl)butyl)-1-piperazinyl)-5-fluoropyrimidine and salts thereof
JPH10130240A (ja) Ｉｃａｍ−１産生阻害剤
CA3191166A1 (en) Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 28
TH63073A (th) อนุพันธ์อินโดลิลเพอริดีนในฐานะเป็นสารต้านฮิสทามีนและสารต้านภูมิแพ้
HK1099244B (en) Tetrahydroindolone derivatives for treatment of neurological conditions
HK1099244A1 (en) Tetrahydroindolone derivatives for treatment of neurological conditions

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired